Advising Nuclera on its US$75 million series C financing
We have advised Nuclera, a biotech company accelerating protein expression and purification workflows based in Cambridge, UK and Boston, US, on its US$75 million series C financing.
The fundraise was led by Elevage Medical Technologies, backed by...
Zur Pressemeldung auf www.taylorwessing.com